| PRODUCTSSERVICESCOMPANYCONTACTFAQ |
|
Description: a chemotherapy regimen consisting of fludarabine, mitoxantrone and prednisone; used for the treatment of recurrent low-grade non-Hodgkin's lymphoma
| 1. | Neoplasms (Cancer)
01/01/2004
- "CONCLUSIONS: The response rate to an FMP regimen was still unsatisfactory, although a specific subgroup of patients (good performance status, smaller liver tumor mass, good liver reserve, and distant metastasis) may benefit from this regimen.We"
Order ALL the reference details at left... |
| 2. | Neoplasm Metastasis (Metastasis)
01/01/2004
- "CONCLUSIONS: The response rate to an FMP regimen was still unsatisfactory, although a specific subgroup of patients (good performance status, smaller liver tumor mass, good liver reserve, and distant metastasis) may benefit from this regimen.We"
Order ALL the reference details at left... |
| 3. | Non-Hodgkin Lymphoma (Lymphosarcoma)
10/01/1995
- "FMP regimen (fludarabine, mitoxantrone, prednisone) as therapy in recurrent low-grade non-Hodgkin's lymphoma."
Order ALL the reference details at left... |
| 1. | Prednisone (Sone)
|
| 2. | Mitoxantrone (Novantrone)
|
| 3. | fludarabine
|
CureHunter Patient-Physician Summary Reports collect in one document all the
medications ever reported in the US National Library of Medicine—1949 to the present—to
be effective against your target disease.
CureHunter research summary reports will vary in length from 25 to 250 pages.
Analytic charts allow you and your physicians to see at a glance your
medication options—including new, promising, off-label and experimental
all rated for clinical efficacy.
| Price: | $24.00
& Delivery via
PDF download
updates for 1 year |
| Price: | $490.00
access via web interface 1 year subscription |
| Price: | $45.00
access via "curehunter.com/m" 1 year subscription |